Publications by authors named "Shimon Slavin"

99Publications

Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies.

Cancer Immunol Immunother 2020 May 9;69(5):683-687. Epub 2020 Mar 9.

Departments of Surgery and Medical Microbiology and Immunology, Alberta Diabetes Institute, Alberta Transplant Institute, University of Alberta, Edmonton, AB, T6G 2E1, Canada.

View Article and Find Full Text PDF
May 2020

Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.

Stem Cell Res Ther 2016 10 10;7(1):149. Epub 2016 Oct 10.

Mina & Everard Goodman Faculty of Life-Sciences, Bar-Ilan University, Ramat-Gan, Israel.

View Article and Find Full Text PDF
October 2016

Transplant of ex vivo incubated bone marrow with rIL -7 for the enhancement of immuno-hematopoietic reconstitution.

Leuk Lymphoma 2015 ;56(12):3387-92

a Department of Bone Marrow Transplantation & Cancer Immunotherapy , Hadassah/Hebrew University Medical Center , Kiryat Hadassah, Jerusalem , Israel.

View Article and Find Full Text PDF
September 2016

Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity.

Pharmacol Res 2014 Jan 4;79:9-12. Epub 2013 Nov 4.

Department of Probability, Alfred Renyi Institute of Mathematics, Hungarian Academy of Sciences, Realtanoda utca 13-15, H-1053 Budapest, Hungary. Electronic address:

View Article and Find Full Text PDF
January 2014

MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.

PLoS One 2013 4;8(2):e54652. Epub 2013 Feb 4.

Davidson Laboratory of Cell Signaling and Tumorigenesis, Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan, USA.

View Article and Find Full Text PDF
July 2013

Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis.

EMBO Mol Med 2012 Apr 20;4(4):313-29. Epub 2012 Feb 20.

The Shraga Segal Department of Immunology and Microbiology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

View Article and Find Full Text PDF
April 2012

Multidonor bone marrow transplantation improves donor engraftment and increases the graft versus tumor effect while decreasing graft-versus-host disease.

Transpl Int 2011 Feb 20;24(2):194-200. Epub 2010 Sep 20.

Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

View Article and Find Full Text PDF
February 2011

Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study.

Cancer Immunol Immunother 2010 Oct 20;59(10):1511-9. Epub 2010 Jun 20.

International Center for Cell Therapy and Cancer Immunotherapy (CTCI), Weizman Center, 14 Weizman Street, Tel Aviv, 64239, Israel.

View Article and Find Full Text PDF
October 2010

Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.

PLoS One 2010 Apr 15;5(4):e10135. Epub 2010 Apr 15.

Department of Bone Marrow Transplantation, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

View Article and Find Full Text PDF
April 2010

Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitis.

Mol Immunol 2010 Jun;47(10):1890-8

Department of Bone Marrow Transplantation, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.

View Article and Find Full Text PDF
June 2010

Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.

PLoS One 2010 Feb 9;5(2):e9132. Epub 2010 Feb 9.

Beilinson Hospital, Rabin Medical Center, Felsenstein Medical Research Center, Petah-Tikva, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

View Article and Find Full Text PDF
February 2010

Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals.

Cytotherapy 2009 ;11(7):837-48

The Shraga Segal Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University, Beer Sheva, Israel.

View Article and Find Full Text PDF
June 2010

Repair of bone defect using bone marrow cells and demineralized bone matrix supplemented with polymeric materials.

Curr Stem Cell Res Ther 2010 Mar;5(1):49-56

Investigator-in-Charge, The international center for Cell Therapy & Cancer Immunotherapy, Top Ichilov at Weizman Center, Tel Aviv Medical Complex, 14 Weizman Street, Tel Aviv 64239, Israel.

View Article and Find Full Text PDF
March 2010

Immunoregulation of GVHD by triggering the innate immune system with CpG.

Expert Rev Hematol 2009 Aug;2(4):443-53

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Laboratory, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
August 2009

A retrospective review of the outcome after second or subsequent allogeneic transplantation.

Biol Blood Marrow Transplant 2009 Apr;15(4):483-9

Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah, Hebrew University Medical Center, Jerusalem, Israel.

View Article and Find Full Text PDF
April 2009

Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.

Biol Blood Marrow Transplant 2009 Apr 12;15(4):406-15. Epub 2009 Feb 12.

Department of Bone Marrow Transplantation & Cancer Immunotherapy, Cell Therapy & Transplantation Research Laboratory, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
April 2009

Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.

Exp Hematol 2008 Dec 21;36(12):1750-9. Epub 2008 Sep 21.

Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
December 2008

CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy.

Biol Blood Marrow Transplant 2008 Sep;14(9):973-984

The International Centre for Cell Therapy and Cancer, Tel Aviv (Souraski) Medical Center, Tel Aviv 64239, Israel.

View Article and Find Full Text PDF
September 2008

Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.

Exp Hematol 2008 Oct 10;36(10):1370-6. Epub 2008 Jul 10.

Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
October 2008

Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production.

Diabetes Metab Res Rev 2008 Jul-Aug;24(5):413-21

Department of Bone Marrow Transplantation, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.

View Article and Find Full Text PDF
September 2008

Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lymphocytes and trifunctional bispecific antibody.

Exp Hematol 2008 Aug 20;36(8):997-1003. Epub 2008 May 20.

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Laboratory, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
August 2008

The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.

Clin Neurol Neurosurg 2008 Nov 6;110(9):943-6. Epub 2008 Mar 6.

International Center for Cell Therapy & Cancer (ICTC), Tel Aviv Medical Center, Tel Aviv, Israel.

View Article and Find Full Text PDF
November 2008

CD44 gene vaccination for insulin-dependent diabetes mellitus in non-obese diabetic mice.

Isr Med Assoc J 2008 Jan;10(1):20-5

Department of Bone Marrow Transplantation and Cancer Research Laboratory, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
January 2008

Hematopoietic stem cell therapy for malignant diseases.

Ann Med 2007 5;39(6):465-73. Epub 2007 Jul 5.

Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah University Hospital, Jerusalem 91120, Israel.

View Article and Find Full Text PDF
January 2008

Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Neuropharmacology 2008 Jan 17;54(1):244-9. Epub 2007 Jul 17.

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel.

View Article and Find Full Text PDF
January 2008

The oxidative status of blood cells in a murine model of graft-versus-host disease.

Ann Hematol 2007 Oct 26;86(10):753-8. Epub 2007 Jul 26.

Department of Hematology, Hadassah University Hospital, Ein-Kerem, POB 12000, Jerusalem, 91120, Israel.

View Article and Find Full Text PDF
October 2007

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.

J Neurol Sci 2008 Feb 3;265(1-2):131-5. Epub 2007 Jul 3.

Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Hospital, Ein-Karem, Jerusalem, IL-91120, Israel.

View Article and Find Full Text PDF
February 2008

Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients.

Exp Hematol 2007 May;35(5):748-56

Department of Bone Marrow Transplantation & Cancer Immunotherapy, Cell Therapy & Transplantation Research Laboratory, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
May 2007

Conversion of red bone marrow into yellow - Cause and mechanisms.

Med Hypotheses 2007 11;69(3):531-6. Epub 2007 Apr 11.

Department of Bone Marrow Transplantation, Cancer Immunotherapy and Immunobiology Research Center, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
October 2007

N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity.

Transpl Immunol 2007 Apr 28;17(3):198-202. Epub 2006 Nov 28.

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

View Article and Find Full Text PDF
April 2007

Osteoporosis of hematologic etiology.

Exp Hematol 2007 Jan;35(1):128-36

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
January 2007

The hematological etiology of osteoporosis.

Med Hypotheses 2006 23;67(4):729-35. Epub 2006 Jun 23.

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, Jerusalem 91120, Israel.

View Article and Find Full Text PDF
October 2006

Biological response modifiers as adjuncts to stem cell transplantation.

Expert Opin Biol Ther 2006 May;6(5):467-83

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel.

View Article and Find Full Text PDF
May 2006

Improved survival following induction of GVHD following lipopolysaccharide immunization.

Exp Hematol 2006 Apr;34(4):549-53

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
April 2006

Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.

Cancer Immunol Immunother 2006 Nov 1;55(11):1330-6. Epub 2006 Feb 1.

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, 91120 Jerusalem, Israel.

View Article and Find Full Text PDF
November 2006

Neuroprotection in multiple sclerosis.

Clin Neurol Neurosurg 2006 Mar 4;108(3):250-4. Epub 2006 Jan 4.

Department of Neurology and the Agnes Ginges Center for Neurogenetics, Laboratory of Neuroimmunology, Hadassah University Hospital, Jerusalem, Ein-Karem IL-91120, Israel.

View Article and Find Full Text PDF
March 2006

Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.

Clin Transplant 2005 Dec;19(6):840-7

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Hebrew University - Hadassah Medical School, Jerusalem, Israel.

View Article and Find Full Text PDF
December 2005

Allogeneic cell-mediated immunotherapy at the stage of minimal residual disease following high-dose chemotherapy supported by autologous stem cell transplantation.

Authors:
Shimon Slavin

Acta Haematol 2005 ;114(4):214-20

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
December 2005

Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.

Cancer Res 2005 Nov;65(21):9735-40

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
November 2005

Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes.

Blood 2006 Feb 18;107(4):1564-9. Epub 2005 Oct 18.

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
February 2006

Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.

Haematologica 2005 Aug;90(8):1089-95

Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah-Hebrew University Medical Center Jerusalem 91120, Israel.

View Article and Find Full Text PDF
August 2005

Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.

Cancer Immunol Immunother 2005 Apr 3;54(4):383-8. Epub 2004 Nov 3.

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, PO Box 12000, 91120, Jerusalem, Israel.

View Article and Find Full Text PDF
April 2005

Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.

Springer Semin Immunopathol 2004 Nov 30;26(1-2):133-42. Epub 2004 Sep 30.

Department of Bone Marrow Transplantation, Cancer Immunotherapy and Immunobiology Research Center, Hadassah University Hospital, P.O.B 12000, 91120 Jerusalem, Israel.

View Article and Find Full Text PDF
November 2004

Non-myeloablative stem cell transplantation for autoimmune diseases.

Springer Semin Immunopathol 2004 Nov 29;26(1-2):57-69. Epub 2004 Jul 29.

Division of Immunotherapy, Northwestern University Feinberg School of Medicine, 320 East Superior, Searle 3-489, Chicago, IL 60611, USA.

View Article and Find Full Text PDF
November 2004

Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.

Exp Hematol 2004 Nov;32(11):1110-7

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
November 2004

Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients.

Blood Cells Mol Dis 2004 Nov-Dec;33(3):238-47

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
April 2005

Reduced intensity versus truly nonmyeloablative conditioning for stem-cell transplant recipients.

Authors:
Shimon Slavin

Transplantation 2004 Oct;78(7):964-5

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, Jerusalem, Israel.

View Article and Find Full Text PDF
October 2004